SKP2 and pulmonary fibrosis: Therefore, Skp2-deficiency may suppress the increase of mesenchymal fibroblasts by BLM-administration and contribute to the suppression of the accumulation of fibrosis-associated proteins in lung tissues, thereby attenuating the progression of pulmonary fibrosis.